Dear {{$doctorName}},
Subject: In-Practice
Usage and Performance (IPUP) Study of Disperzyme
Study code: Classic
/IPUP/Disperzyme/ 2023
Systemic enzyme therapy
(SET) involves the use of proteolytic enzymes, also called
proteases, which are naturally occurring substances derived from
animal or plant sources.
Combined with the bioflavonoid Rutin (Rutoside), the proteases
Trypsin and Bromelain
have been extensively investigated as alternatives to conventional
pharmaceutical
treatments for pain and swelling associated with several common
conditions including
ankle injuries , knee arthritis ,hip arthritis and post-surgical
management of general
surgery, orthopaedic, and dental procedures.
Disperzyme is an orally
administered dispersible tablet contain Trypsin BP 96mg +
Bromelain 180mg+ Rutoside trihydrate BP 200 mg, & are marketed by
the ‘Classic’ team
of Sun Pharmaceutical Industries Ltd.
Although every product is
marketed only after regulatory approval, it is important to
know how it performs in day-to-day practice of individual medical
practitioners. For this
purpose, we have planned to conduct a prospective study to assess
the real-life
performance of ‘Disprzyme” in your patients.
We
invite you to participate in this study. All you need to do is to
report on a standard
form your experience with ‘Disperzyme’ in {{$numberOfPatient}} consecutive patients in
whom you
prescribe this product in the normal course of your practice. Thus,
this is not an
experimental study because the product will be prescribed and
purchased as you and your
patients normally do.
If you
agree to participate, you will need to copy the relevant information
from the
suggested number of patient’s case papers on to the standard case
report forms. Let us
assure you that the CRF will not contain the patients’ names, so as
to ensure
confidentiality. If any serious adverse events (AE) occur during
‘Disperzyme therapy, you
will be expected to report them to us immediately on the AE
reporting form.
As you
will be spending some extra time to keep, copy and verify these
patient’s records,
we offer to pay you by cheque a professional fee of Rs. {{$contractAmount}}/-
.
We trust
you and we are partners in promoting safe and effective drug
therapy. In that spirit, we hope you will consent to participate in
this study. If you do, please sign and
return the enclosed reply along with your visiting card for accuracy
of records.
|
}}){kind=logo}